There may be a bit of a sentiment rally around China’s recovery, says JPMorgan’s Meera Pandit
Meera Pandit, JPMorgan Asset Management global market strategist, joins ‘Closing Bell’ to discuss positioning in 2024 in the bond and global markets.
Similar Posts
Saudi’s pumping more oil & slowing global demand say sell
Will oil continue to slide lower as the Saudis ramp up production following the attack? With CNBC’s Seema Mody and the Futures Now traders, Jim Iuorio at the CME and Anthony Grisanti at the NYMEX.
Nasdaq CEO: 2023 IPOs performing well should give investors a ‘boost of confidence’
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Adena Friedman, Nasdaq CEO, joins ‘Closing Bell Overtime’ to talk possible IPOs in 2024, market volatility, AI investing and more. 05:04 Wed, Jan 10 20245:28 PM EST
Oppenheimer’s Colin Rusch on Wolfspeed shares: There’s substantial upside to earnings growth
Colin Rusch, Oppenheimer, joins ‘Closing Bell’ to discuss Wolfspeed shares turning positive on the year.
‘Squawk on the Street’ crew react to December’s CPI report
CNBC’s Carl Quintanilla and Jim Cramer break down December’s CPI data.
Watch CNBC’s full interview with Trivariate Research’s Adam Parker and Wealth Enhancement’s Nicole Webb
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Trivariate Research CEO Adam Parker and Nicole Webb, senior vice president and financial advisor at Wealth Enhancement Group, join ‘Closing Bell’ to discuss their market outlook for 2024, expectations from the Fed, and more. 19:36 Tue, Jan 9 20243:35 PM EST
Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
